Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 5304391, 6 pages
https://doi.org/10.1155/2017/5304391
Research Article

Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy

1Department of Clinical Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
2Department of Endocrinology and Metabolism, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China

Correspondence should be addressed to Jue Zhang; moc.liamtoh@524eujgnahz and Hao Lu; moc.361@304oahul

Received 14 December 2016; Revised 16 May 2017; Accepted 28 May 2017; Published 4 July 2017

Academic Editor: Janaka Karalliedde

Copyright © 2017 Jianzhong Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” Journal of the American Medical Association, vol. 310, pp. 948–959, 2013. View at Google Scholar
  3. E. Selvin, C. M. Parrinello, D. B. Sacks, and J. Coresh, “Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010,” Annals of Internal Medicine, vol. 160, pp. 517–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants,” Lancet (London, England), vol. 378, pp. 31–40, 2011. View at Google Scholar
  5. H. Noto, A. Goto, T. Tsujimoto, K. Osame, and M. Noda, “Latest insights into the risk of cancer in diabetes,” Journal of Diabetes Investigation, vol. 4, pp. 225–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. B. Barone, H. C. Yeh, C. F. Snyder et al., “Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 300, pp. 2754–2764, 2008. View at Google Scholar
  7. E. Giovannucci, D. M. Harlan, M. C. Archer et al., “Diabetes and cancer: a consensus report,” Diabetes Care, vol. 33, pp. 1674–1685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Carstensen, D. R. Witte, and S. Friis, “Cancer occurrence in Danish diabetic patients: duration and insulin effects,” Diabetologia, vol. 55, pp. 948–958, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, pp. 87–108, 2015. View at Google Scholar
  10. J. Schneider, “Tumor markers in detection of lung cancer,” Advances in Clinical Chemistry, vol. 42, pp. 1–41, 2006. View at Google Scholar
  11. F. Chen, X. Y. Wang, X. H. Han, H. Wang, and J. Qi, “Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease,” International Journal of Clinical and Experimental Medicine, vol. 8, pp. 11295–11300, 2015. View at Google Scholar
  12. N. Arik, B. Adam, T. Akpolat, K. Hasil, and S. Tabak, “Serum tumour markers in renal failure,” International Urology and Nephrology, vol. 28, pp. 601–604, 1996. View at Publisher · View at Google Scholar
  13. F. Nomura, A. Koyama, M. Ishijima, S. Takano, M. Narita, and T. Nakai, “Serum levels of five tumor markers for lung cancer in patients with chronic renal failure,” Oncology Reports, vol. 5, pp. 389–392, 1998. View at Google Scholar
  14. Y. Xiaofang, Z. Yue, X. Xialian, and Y. Zhibin, “Serum tumour markers in patients with chronic kidney disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 67, pp. 661–667, 2007. View at Google Scholar
  15. H. L. Tong, Z. N. Dong, X. Y. Wen, J. Gao, B. Wang, and Y. P. Tian, “Impact of chronic kidney disease on serum tumor markers concentrations,” Chinese Medical Journal, vol. 126, pp. 274–279, 2013. View at Google Scholar
  16. J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz, “Diabetic nephropathy: diagnosis, prevention, and treatment,” Diabetes Care, vol. 28, pp. 164–176, 2005. View at Google Scholar
  17. R. Gupta and A. Misra, “Epidemiology of microvascular complications of diabetes in south Asians and comparison with other ethnicities,” Journal of Diabetes, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Molitch, R. A. DeFronzo, M. J. Franz, W. F. Keane, C. E. Mogensen, and H. H. Parving, “Diabetic nephropathy,” Diabetes Care, vol. 26, Supplement 1, pp. S94–S98, 2003. View at Google Scholar
  19. X. Lv, W. Sun, X. Huang et al., “Association of serum fetuin-A levels with the risk of albuminuria in middle-aged and elderly Chinese,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, pp. 1235–1242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wu, X. Li, Y. Tao, Y. Wang, and Y. Peng, “Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes,” International Journal of Endocrinology, vol. 2015, p. 204893, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. D. W. Yang, Y. Zhang, Q. Y. Hong et al., “Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients,” Cancer, vol. 121, Supplement 17, pp. 3113–3121, 2015. View at Google Scholar
  22. K. Kashiwabara, K. Kishi, H. Nakamura et al., “Mechanism of increased serum cytokeratin 19 fragment levels in patients with diabetic nephropathy as a model of chronic renal failure,” Internal Medicine (Tokyo, Japan), vol. 37, pp. 917–921, 1998. View at Publisher · View at Google Scholar
  23. G. Coppolino and D. Bolignano, “Tumour markers and kidney function: a systematic review,” BioMed Research International, vol. 2014, Article ID 647541, 9 pages, 2014. View at Google Scholar
  24. D. Liu, M. Xu, L. H. Ding et al., “Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation,” The International Journal of Biochemistry & Cell Biology, vol. 57, pp. 7–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. H. F. Jheng, P. J. Tsai, Y. L. Chuang et al., “Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy,” Disease Models & Mechanisms, vol. 8, pp. 1311–1321, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Trape, X. Filella, M. Alsina-Donadeu, L. Juan-Pereira, A. Bosch-Ferrer, and R. Rigo-Bonnin, “Increased plasma concentrations of tumour markers in the absence of neoplasia,” Clinical Chemistry and Laboratory Medicine, vol. 49, pp. 1605–1620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Narita, H. Sasaki, M. Hosoba et al., “Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients,” Diabetes Care, vol. 27, pp. 1176–1181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. W. J. Fu, S. L. Xiong, Y. G. Fang et al., “Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study,” Endocrine, vol. 41, pp. 82–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Gluhovschi, G. Gluhovschi, L. Petrica et al., “Urinary biomarkers in the assessment of early diabetic nephropathy,” Journal of Diabetes Research, vol. 2016, Article ID 4626125, 13 pages, 2016. View at Google Scholar
  30. J. Surendar, S. Anuradha, B. Ashley et al., “Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32),” Metabolic Syndrome and Related Disorders, vol. 7, pp. 419–425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Pugliese, A. Solini, C. Fondelli et al., “Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and cardiovascular events (RIACE) study,” Nephrology, Dialysis, Transplantation, vol. 26, pp. 3950–3954, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. Tahrani, A. Ali, N. T. Raymond et al., “Obstructive sleep apnea and diabetic nephropathy: a cohort study,” Diabetes Care, vol. 36, pp. 3718–3725, 2013. View at Publisher · View at Google Scholar · View at Scopus